Zentek (STU:ZAY) Other Current Receivables: €0.22 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:ZAY Zentek Ltd STU:ZAY
29 GF Score
Price €0.45
! 4 Warning Signs
View Full Analysis

What is Zentek Other Current Receivables?

Zentek STU:ZAY -5.08% 29 Other Current Receivables is €0.22 Mil as of Mar. 2026. GuruFocus rates STU:ZAY with a GF Score™ of 29/100. The stock has 4 warning signs investors should review.

Zentek's Other Current Receivables for the quarter that ended in Mar. 2026 was €0.22 Mil.

Zentek's quarterly Other Current Receivables increased from Sep. 2025 (€0.08 Mil) to Dec. 2025 (€0.23 Mil) but then stayed the same from Dec. 2025 (€0.23 Mil) to Mar. 2026 (€0.22 Mil).

Zentek's annual Other Current Receivables increased from Mar. 2024 (€0.20 Mil) to Mar. 2025 (€0.26 Mil) but then declined from Mar. 2025 (€0.26 Mil) to Mar. 2026 (€0.22 Mil).

Zentek Other Current Receivables Related Terms

Zentek Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Zentek's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zentek Other Current Receivables Chart

Zentek Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.38 0.20 0.26 0.22

Zentek Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.16 0.08 0.23 0.22
STU:ZAY
29GF Score
Zentek Ltd STU:ZAY
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zentek Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.22 Mil mean?
Zentek (STU:ZAY) has a Other Current Receivables of €0.22 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Zentek and its competitors.
Is Zentek's Other Current Receivables too high?
Zentek's current Other Current Receivables is €0.22 Mil. Overall, Zentek has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Zentek's Other Current Receivables compare to ISRG and BDX?
Zentek's Other Current Receivables of €0.22 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Zentek and its competitors. Zentek's current Other Current Receivables is €0.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zentek stock overvalued right now?
Zentek (STU:ZAY) has a current Other Current Receivables of €0.22 Mil. The current Other Current Receivables is €0.22 Mil. Zentek's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Zentek (STU:ZAY), the current Other Current Receivables is €0.22 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zentek Business Description

Other Exchanges ZTEK:USAZEN:Canada
Address 24 Corporate Court, Guelph, ON, CAN, N1G 5G5
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
29GF Score

Get the complete analysis for STU:ZAY

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.45
Price